IP Library Granted Patent US 11,541,235
Granted Patent B2
US 11,541,235 · App. 15/688,418 · Granted Jan 3, 2023

Devices and methods for delivery of electrical current for pain relief

Inventors: Joseph W. Boggs (Chapel Hill, NC); Amorn Wongsarnpigoon (Chapel Hill, NC); Matthew G. deBock (Morrisville, NC); Nathan Crosby (Cleveland, OH)
Assignee: SPR THERAPEUTICS, INC.
A61N1/36021A61N1/36017A61N1/36071A61N1/0502A61N1/36034
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,541,235
App. No.
15/688,418
Granted
Jan 3, 2023
Kind
B2
Abstract

Device/system that provides pain relief by delivering stimulation that neither generates action potentials nor completely blocks neural transmission (in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve). The present teachings provide relief by modulating release of neurotransmitters in peripheral nerves to cause neuromodulation at the level of the peripheral nerve (modulation of neural signals in the peripheral nerve) to alter the frequency of physiologically generated neural transmission.

Claims (28)

1. A method of treating pain comprising:

deploying an open-coiled lead comprising an electrode, wherein the electrode is deployed outside of a central nervous system;

delivering electric current through the electrode to one peripheral nerve tissue;

altering, through the electric current, transmission and production of action potentials in the one peripheral nerve tissue, which is selected from a nerve cell body, dendrites, axons, axon hillocks, or other nerve fibers, wherein the altering occurs without directly stimulating an action potential in the peripheral nerve tissue; and

changing probability of action potentials occurring as a result of the electric current;

changing excitability of at least one nerve as a result of the electric current; and

changing conduction velocity, shape, or interpulse interval of action potentials as a result of the electric current and wherein the electrical current does not block or interrupt efferent signals and motor nerve signals.

2. The method of claim 1 , wherein the electrical current does not cause paresthesias.

3. The method of claim 1 wherein the electrical current alters action potentials in neural targets via activation, inactivation, excitation, or suppression of non-neural tissue.

4. The method of claim 3 wherein the non-neural tissue is a glial cell.

5. The method of claim 1 wherein the electrical current is delivered through the electrode located 1.0 mm or more away from the nerve tissue.

6. The method of claim 1 , wherein the electric current causes changes to a frequency of action potentials.

7. The method of claim 1 , wherein the electric current causes changes to form, features, period, rate, coefficient of variation, or duration of action potentials.

8. The method of claim 7 , wherein the electric current causes changes to timing, spacing, or pattern of action potentials or trains of action potentials.

9. The method of claim 1 , wherein the electric current causes changes to a frequency of action potentials and changes to form, features, period, rate, coefficient of variation, or duration of action potentials.

10. A method of treating pain comprising:

deploying an open-coiled lead into a tissue, the lead comprising an electrode positioned outside of a central nervous system;

altering transmission of action potentials in one peripheral nerve tissue selected from a nerve cell body (or soma), dendrites, axons, axon hillocks, or other nerve fibers

changing a probability of action potentials occurring through application of electrical stimulation via the electrode;

changing excitability of at least one nerve of said peripheral nerve tissue through the application of the electrical stimulation via the electrode; and

changing conduction velocity, shape, or interpulse interval of action potentials through the application of the electrical stimulation via the electrode wherein the electrical current does not block or interrupt efferent signals and motor nerve signals.

11. A method of treating pain comprising:

deploying an open-coiled lead into a tissue, the lead comprising an electrode positioned outside of a central nervous system;

delivering electric current to one peripheral nerve via the electrode;

altering transmission and production of action potentials in the one peripheral nerve tissue selected from a nerve cell body, dendrites, axons, axon hillocks, or other nerve fibers without directly stimulating an action potential in the peripheral nerve tissue;

changing probability action potentials occurring caused by the electric current;

changing excitability of at least one nerve caused by the electric current; and

changing conduction velocity, shape, interpulse interval of action potentials caused by the electric current and wherein the electrical current does not block or interrupt efferent signals and motor nerve signals.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2018
From: BOGGS, JOSEPH W.; CROSBY, NATHAN; WONGSARNPIGOON, AMORN; DEBOCK, MATTHEW G.
To: SPR THERAPEUTICS, INC.
Reel/Frame 046719/0499 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
Continuity (2)
Provisional Application 62380097 · Aug 26, 2016
Related Publication 20180056066A1 · Mar 1, 2018
Cited By (1)
US 12,377,272